Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes
Schmidt et al. evaluate the effects of elevated circulating concentrations of cholesterol-containing lipoproteins and apolipoproteins. Effects are seen on measures of atherosclerosis, blood pressure, c-reactive protein, coronary heart disease, heart failure, Alzheimer’s disease, type 2 diabetes and...
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2023-01-01
|
| Series: | Communications Medicine |
| Online Access: | https://doi.org/10.1038/s43856-022-00234-0 |
| _version_ | 1797945758471684096 |
|---|---|
| author | Amand F. Schmidt Roshni Joshi Maria Gordillo-Marañón Fotios Drenos Pimphen Charoen Claudia Giambartolomei Joshua C. Bis Tom R. Gaunt Alun D. Hughes Deborah A. Lawlor Andrew Wong Jackie F. Price Nishi Chaturvedi Goya Wannamethee Nora Franceschini Mika Kivimaki Aroon D. Hingorani Chris Finan |
| author_facet | Amand F. Schmidt Roshni Joshi Maria Gordillo-Marañón Fotios Drenos Pimphen Charoen Claudia Giambartolomei Joshua C. Bis Tom R. Gaunt Alun D. Hughes Deborah A. Lawlor Andrew Wong Jackie F. Price Nishi Chaturvedi Goya Wannamethee Nora Franceschini Mika Kivimaki Aroon D. Hingorani Chris Finan |
| author_sort | Amand F. Schmidt |
| collection | DOAJ |
| description | Schmidt et al. evaluate the effects of elevated circulating concentrations of cholesterol-containing lipoproteins and apolipoproteins. Effects are seen on measures of atherosclerosis, blood pressure, c-reactive protein, coronary heart disease, heart failure, Alzheimer’s disease, type 2 diabetes and inflammatory bowel disease. |
| first_indexed | 2024-04-10T21:00:11Z |
| format | Article |
| id | doaj.art-a4840a392ca142fd8b56739e6ab3255e |
| institution | Directory Open Access Journal |
| issn | 2730-664X |
| language | English |
| last_indexed | 2024-04-10T21:00:11Z |
| publishDate | 2023-01-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Communications Medicine |
| spelling | doaj.art-a4840a392ca142fd8b56739e6ab3255e2023-01-22T12:23:18ZengNature PortfolioCommunications Medicine2730-664X2023-01-013111010.1038/s43856-022-00234-0Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomesAmand F. Schmidt0Roshni Joshi1Maria Gordillo-Marañón2Fotios Drenos3Pimphen Charoen4Claudia Giambartolomei5Joshua C. Bis6Tom R. Gaunt7Alun D. Hughes8Deborah A. Lawlor9Andrew Wong10Jackie F. Price11Nishi Chaturvedi12Goya Wannamethee13Nora Franceschini14Mika Kivimaki15Aroon D. Hingorani16Chris Finan17Institute of Cardiovascular Science, Faculty of Population Health, University College LondonInstitute of Cardiovascular Science, Faculty of Population Health, University College LondonInstitute of Cardiovascular Science, Faculty of Population Health, University College LondonInstitute of Cardiovascular Science, Faculty of Population Health, University College LondonInstitute of Cardiovascular Science, Faculty of Population Health, University College LondonIstituto Italiano di Tecnologia, Non-coding RNAs and RNA-based TherapeuticsCardiovascular Health Research Unit, Department of Medicine, University of WashingtonMRC Integrative Epidemiology Unit, Bristol Medical School, University of BristolInstitute of Cardiovascular Science, Faculty of Population Health, University College LondonMRC Integrative Epidemiology Unit, Bristol Medical School, University of BristolMRC Unit for Lifelong Health and Ageing, University College LondonUsher Institute, University of EdinburghInstitute of Cardiovascular Science, Faculty of Population Health, University College LondonPrimary Care and Population Health, University College LondonDepartment of Epidemiology, Gillings School of Global Public Health, University of North CarolinaDepartment of Mental Health of Older People, Division of Brain Sciences, University College LondonInstitute of Cardiovascular Science, Faculty of Population Health, University College LondonInstitute of Cardiovascular Science, Faculty of Population Health, University College LondonSchmidt et al. evaluate the effects of elevated circulating concentrations of cholesterol-containing lipoproteins and apolipoproteins. Effects are seen on measures of atherosclerosis, blood pressure, c-reactive protein, coronary heart disease, heart failure, Alzheimer’s disease, type 2 diabetes and inflammatory bowel disease.https://doi.org/10.1038/s43856-022-00234-0 |
| spellingShingle | Amand F. Schmidt Roshni Joshi Maria Gordillo-Marañón Fotios Drenos Pimphen Charoen Claudia Giambartolomei Joshua C. Bis Tom R. Gaunt Alun D. Hughes Deborah A. Lawlor Andrew Wong Jackie F. Price Nishi Chaturvedi Goya Wannamethee Nora Franceschini Mika Kivimaki Aroon D. Hingorani Chris Finan Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes Communications Medicine |
| title | Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes |
| title_full | Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes |
| title_fullStr | Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes |
| title_full_unstemmed | Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes |
| title_short | Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes |
| title_sort | biomedical consequences of elevated cholesterol containing lipoproteins and apolipoproteins on cardiovascular and non cardiovascular outcomes |
| url | https://doi.org/10.1038/s43856-022-00234-0 |
| work_keys_str_mv | AT amandfschmidt biomedicalconsequencesofelevatedcholesterolcontaininglipoproteinsandapolipoproteinsoncardiovascularandnoncardiovascularoutcomes AT roshnijoshi biomedicalconsequencesofelevatedcholesterolcontaininglipoproteinsandapolipoproteinsoncardiovascularandnoncardiovascularoutcomes AT mariagordillomaranon biomedicalconsequencesofelevatedcholesterolcontaininglipoproteinsandapolipoproteinsoncardiovascularandnoncardiovascularoutcomes AT fotiosdrenos biomedicalconsequencesofelevatedcholesterolcontaininglipoproteinsandapolipoproteinsoncardiovascularandnoncardiovascularoutcomes AT pimphencharoen biomedicalconsequencesofelevatedcholesterolcontaininglipoproteinsandapolipoproteinsoncardiovascularandnoncardiovascularoutcomes AT claudiagiambartolomei biomedicalconsequencesofelevatedcholesterolcontaininglipoproteinsandapolipoproteinsoncardiovascularandnoncardiovascularoutcomes AT joshuacbis biomedicalconsequencesofelevatedcholesterolcontaininglipoproteinsandapolipoproteinsoncardiovascularandnoncardiovascularoutcomes AT tomrgaunt biomedicalconsequencesofelevatedcholesterolcontaininglipoproteinsandapolipoproteinsoncardiovascularandnoncardiovascularoutcomes AT alundhughes biomedicalconsequencesofelevatedcholesterolcontaininglipoproteinsandapolipoproteinsoncardiovascularandnoncardiovascularoutcomes AT deborahalawlor biomedicalconsequencesofelevatedcholesterolcontaininglipoproteinsandapolipoproteinsoncardiovascularandnoncardiovascularoutcomes AT andrewwong biomedicalconsequencesofelevatedcholesterolcontaininglipoproteinsandapolipoproteinsoncardiovascularandnoncardiovascularoutcomes AT jackiefprice biomedicalconsequencesofelevatedcholesterolcontaininglipoproteinsandapolipoproteinsoncardiovascularandnoncardiovascularoutcomes AT nishichaturvedi biomedicalconsequencesofelevatedcholesterolcontaininglipoproteinsandapolipoproteinsoncardiovascularandnoncardiovascularoutcomes AT goyawannamethee biomedicalconsequencesofelevatedcholesterolcontaininglipoproteinsandapolipoproteinsoncardiovascularandnoncardiovascularoutcomes AT norafranceschini biomedicalconsequencesofelevatedcholesterolcontaininglipoproteinsandapolipoproteinsoncardiovascularandnoncardiovascularoutcomes AT mikakivimaki biomedicalconsequencesofelevatedcholesterolcontaininglipoproteinsandapolipoproteinsoncardiovascularandnoncardiovascularoutcomes AT aroondhingorani biomedicalconsequencesofelevatedcholesterolcontaininglipoproteinsandapolipoproteinsoncardiovascularandnoncardiovascularoutcomes AT chrisfinan biomedicalconsequencesofelevatedcholesterolcontaininglipoproteinsandapolipoproteinsoncardiovascularandnoncardiovascularoutcomes |